Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Early Stability of Short vs. Standard Dental Implants in the Posterior Mandible
This study compares how well short dental implants (7mm) work compared to standard-length implants (11mm) when placed in the back part of the lower jaw. Both types of implants have special shallow threads designed to reduce stress on the bone. The main goal is to see how stable they are during the first 4 weeks after placement-a critical time for healing.
What will happen in the study?
Screening: A dental exam and 3D scan to check bone quality.
Implant Placement:
Follow-ups: Painless stability checks at end of 1, 2, 3, and 4 weeks using a small device (RFA).
Who can participate?
Adults (18-60 years) missing posterior teeth in the lower jaw, with:
How long is the study?
A prospective, controlled, parallel-group pilot clinical trial comparing 7mm short implants (SHI) versus 11mm standard implants (SDI) with identical shallow-thread macrodesign (depth <0.5mm) and 4.2mm diameter. Implant allocation is anatomically driven based on CBCT-measured vertical bone height (7mm group: 8.5-9mm residual bone; 11mm group: ≥12.5mm).
Technical Innovations
Thread Geometry: Dual shallow-thread reverse-buttress design (0.2-0.5mm depth) with progressive pitch to optimize cortical engagement while minimizing shear stress (Ao et al. 2010).
Surgical Protocol: Standardized osteotomy using under-drilling for D2 bone (final drill diameter reduced by 0.2mm) and non-condensing drilling for D3 bone to prevent over-compression.
Stability Metrics:
Bone Density Integration
Quality Controls
Rationale for 4-Week Endpoint
Focuses on the critical early healing phase where:
Technical Constraints
Innovative Aspects
First clinical study to combine:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Short Dental Implant Group. | Experimental | Group A, Shallow-Threaded ,length 7mm, diameter 4.2mm,10 single dental implants. |
|
| Standard Dental Implant Group. | Active Comparator | Group B, Shallow-Threaded ,length 11mm, diameter 4.2mm,10 single dental implants. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Shallow-Threaded Short Implant (SHI) | Device | A 7mm long, 4.2mm diameter dental implant with shallow thread (<0.5mm depth) Macrodesign, surgically placed in the jawbone to restore missing teeth |
| Measure | Description | Time Frame |
|---|---|---|
| Implant Stability Quotient (ISQ) at Baseline (T0) | Mean Resonance frequency Analysis(RFA) measurement taken immediately post-implantation(T0), to assess primary mechanical stability. ISQ range 1-100, low stability <60, medium stability 60 to 69, high more than or equal 70. Reported as mean ISQ value per group. | Measurement at implant placement(Day 0) |
| Insertion Torque value- ITV. | The rotational torque in Ncm,applied during the final quarter-turn of implant insertion. This is direct measure of primary mechanical stability. Reported as mean ITV per group. | Measurement at during implant placement (intraoperative) |
| Magnitude of Stability Dip | The mean lowest point of stability curve , calculated as the greatest negative change in ISQ value from the baseline T0, measurement for each implant during the 4 -week monitoring period. | from implant placement (Day 0) through week4 |
| Time of Onset of Secondary Stability | The mean time in days post implantation at which the ISQ value begins to consistently increase, indicating the start biological secondary stability. Defined as the time point after the nadir -T2or T3.where the ISQ value shows a positive increase confirmed at the subsequent measurement. | from Day0 , through week 4. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
1. Uncontrolled systemic diseases (e.g., diabetes with HbA1c >7%, liver disease) or medications affecting bone healing (e.g., corticosteroids, bisphosphonates).
2. History of head/neck radiotherapy (with in past year). 3. Heavy smoking (>10 cigarettes/day). 4. Absolute contraindications for oral surgery (e.g., recent MI/CVA < 6months, bleeding disorders).
5. Active periodontal disease, parafunctional habits as bruxism, or prior bone grafting at the site.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| university of Sciences and Technology | Sanaa | 009671 | Yemen |
Anonymized data available upon request after publication
6 months from 21/07/2025
De-identified individual participant data will be made available upon reasonable request to corresponding author . Requests require a methodology sound proposal and a signed data access agreement.
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Nov 15, 2025 | |
| Reset | Dec 5, 2025 | |
| Release | Dec 6, 2025 | |
| Reset | Dec 23, 2025 | |
| Release | Dec 23, 2025 | |
| Reset | Jan 14, 2026 | |
| Release | Feb 24, 2026 | |
| Reset | Mar 17, 2026 | |
| Release | May 3, 2026 | |
| Unrelease | May 15, 2026 | |
| Release | May 15, 2026 | |
| Reset | Jun 11, 2026 |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_ICF | Yes | No | Yes | Study Protocol and Informed Consent Form | Aug 19, 2025 | Sep 4, 2025 | Prot_ICF_000.pdf |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Nov 15, 2025 | Dec 5, 2025 | |||
| Dec 6, 2025 |
| ID | Term |
|---|---|
| D016301 | Alveolar Bone Loss |
| ID | Term |
|---|---|
| D001862 | Bone Resorption |
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
| D055093 | Periodontal Atrophy |
Not provided
Not provided
Interventional Study A Prospective, controlled, parallel-group, anatomically allocated pilot study
. Anatomically-Driven Allocation
Group A (Short Implants): 7mm implants placed in sites with 8.5-9mm residual bone height (measured from crest to inferior alveolar nerve + 1.5mm safety margin).
Group B (Standard Implants): 11mm implants placed in sites with ≥12.5mm bone height.
Rationale: Mimics real-world clinical decision-making where implant length is determined by available bone anatomy.
2. Technical Controls:
Standardized diameter: All implants 4.2mm (Tiologic Twinfit system).
Identical surface/macrodesign: SLA surface, shallow threads (<0.5mm depth), reverse-buttress profile.
Surgical calibration: Single operator, under-drilling protocol for D2 bone (final drill -0.2mm), non-condensing drilling for D3 bone.
3. Dynamic Monitoring Protocol:
Timepoints: T0 immediate, T1,T2,T3,T4 (at the end of weeks- 1,2,3,4)
Not provided
Not provided
This clinical trial employs partial masking (blinding) to minimize bias in outcome assessments:
Blinded Parties
Non-Blinded Parties
Blinding Methods
| Shallow-Threaded Standard Implant (SDI) | Device | A 11mm long, 4.2mm diameter dental implant with shallow thread (<0.5mm depth) macrodesign, surgically placed in the jawbone to restore missing teeth. |
|
| Dec 23, 2025 |
| Dec 23, 2025 | Jan 14, 2026 |
| Feb 24, 2026 | Mar 17, 2026 |
| May 3, 2026 | May 15, 2026 |
| May 15, 2026 | Jun 11, 2026 |
| D010510 |
| Periodontal Diseases |
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |